Effects of Ultrasound-Guided Thoracic Paravertebral Nerve Block Combined with Perineural or IV Dexmedetomidine on Acute and Chronic Pain After Thoracoscopic Resection of Lung Lesions: A Double-Blind Randomized Trial
DOI: https://doi.org/10.2147/dddt.s457334
IF: 4.3188
2024-06-11
Drug Design Development and Therapy
Abstract:Zheping Chen, 1, &ast Changli Gao, 1, 2, &ast Yingchao Zhang, 1, 3 Yongxu Gao, 1, 4 Le Zhang, 1 Shanshan Zhao, 1 He Zhang, 1 Xin Zhao, 1 Yanwu Jin 1 1 Department of Anesthesiology, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 2 Department of Anesthesiology, Laoling People Hospital, Laoling, People's Republic of China; 3 Department of Anesthesiology, Shouguang People Hospital, Weifang, People's Republic of China; 4 Department of Anesthesiology, Jinan Third People's Hospital, Laoling, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yanwu Jin, Department of Anesthesiology, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Bei Yuan Street, Jinan, 250033, People's Republic of China, Tel +86-17660085535, Email Background: Thoracic paravertebral block (TPVB) analgesia can be prolonged by local anesthetic adjuvants such as dexmedetomidine. This study aimed to evaluate the two administration routes of dexmedetomidine on acute pain and chronic neuropathic pain (NeuP) prevention compared with no dexmedetomidine. Methods: A total of 216 patients were randomized to receive TPVB using 0.4% ropivacaine alone (R Group), with perineural dexmedetomidine 0.5 μg·kg − 1 (RD 0.5 Group) or 1.0 μg·kg − 1 (RD 1.0 Group), or intravenous (IV) dexmedetomidine 0.5 μg·kg − 1 ·h − 1 (RD iv Group). The primary outcome was the incidence of chronic NeuP, defined as a Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain score > 12 points at 3-month after surgery. Results: (1) For the primary outcome, RD 0.5 Group and RD 1.0 Group demonstrated a decreased incidence of chronic NeuP at 3-month after surgery; (2) Compared with R Group, RD iv Group, RD 0.5 Group, and RD 1.0 Group can reduce VAS scores at rest and movement and Prince-Henry Pain scores at 12 and 24-h after surgery, the consumption of oral morphine equivalent (OME) and improve QOD-15 at POD1; (3) Compared with RD iv Group, RD 0.5 Group and RD 1.0 Group can reduce VAS scores at rest and movement and Prince-Henry Pain scores at 12 and 24-h after surgery, the consumption of postoperative OME and improve QOD-15 at POD1; (4) Compared with RD 0.5 Group, RD 1.0 Group effectively reduced VAS scores at rest at 12 and 24-h after surgery, VAS scores in movement and Prince-Henry Pain scores at 12-h after surgery. However, RD 1.0 Group showed an increased incidence of drowsiness. Conclusion: Perineural or IV dexmedetomidine are similarly effective in reducing acute pain, but only perineural dexmedetomidine reduced chronic NeuP. Moreover, considering postoperative complications such as drowsiness, perineural dexmedetomidine (0.5 μg·kg − 1 ) may be a more appropriate choice. Clinical Trial Registration: Chinese Clinical Trial Registry (ChiCTR2200058982). Keywords: dexmedetomidine, thoracic paravertebral nerve block, neuropathic pain, thoracoscopic surgery Chronic postsurgical pain (CPSP) can sometimes last for a long period after surgery and has been identified as a disabling consequence that seriously impacts patient health and quality of life. 1 Its prevalence has been reported to range between 3% and 85%, depending on the type of operation. 2 CPSP is one of the more common complications following thoracic surgery, and a meta-analysis reported that chronic pain at 3 and 6-month after thoracic surgery was 57% and 47%, respectively. 2–4 CPSP is composed of both nociceptive and neuropathic (also called "neurogenic") components. 5 A significant proportion of CPSP is neuropathic pain (NeuP). NeuP is results from a specific injury or illness that affects the somatosensory system. 6,7 Compared with non-neuropathic chronic pain, NeuP is generally more intense. 6,8 According to the updated classification of chronic pain in the International Statistical Classification of Diseases and Related Health Problems (ICD)-11, NeuP is first categorized into peripheral and central NeuP. 7 The proposal suggests that chronic NeuP can occur after peripheral nerve injury, with exacerbation observed post-surgery. 9–11 Previous research has demonstrated that intraoperative nerve impairment during thoracotomy can lead to the development of chronic NeuP. 11 Video-assisted thoracoscopic surgery (VATS) min -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal